Skip to content

Clinical trials

Multiple Myeloma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Country / region: Netherlands Clear all

128 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20042
20063
20084
20092
20103
20116
20125
20134
20146
20155
20167
201710
20183
20199
20209
202112
202211
20237
20246
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64
Active, not recruiting26
Recruiting21
Terminated8
Unknown status6
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC28
Celgene12
GlaxoSmithKline7
Amgen6
Stichting European Myeloma Network6
European Myeloma Network B.V.5
Bristol-Myers Squibb4
Pfizer4
AbbVie3
Amsterdam UMC, location VUmc3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma128
Recurrence23
Neoplasms8
Neoplasms, Plasma Cell8
Leukemia, Myeloid, Acute7
Hematologic Neoplasms6
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Lymphoma, Large B-Cell, Diffuse5

Trials

Showing 51 to 75 of 128. Each trial links to its page on Pharma Observatory.

28 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.